Madrigal Pharmaceuticals: Truist Securities raises target price to $743 from $709
MDGL•Truist Securities raised its target price for Madrigal Pharmaceuticals to $743 from $709.
Related News
Graphic Packaging Holding Company: JPMorgan raises target price to $12 from $11.5
GPK•
Tempus AI target price raised to $95 from $76
TEM•
U.S. bonds rally as Democrat sweep seen stalling spending
TLT•
Needham cuts Adtran Holdings target price to $9 from $14
ADTN•
Guggenheim cuts Travere Therapeutics target price to $78 from $89
TVTX•